Biotech Growth (UK) Today
| BIOG Stock | 898.00 12.00 1.35% |
Performance0 of 100
| Odds Of DistressLess than 1
|
Biotech Growth is selling for under 898.00 as of the 3rd of February 2025; that is 1.35 percent increase since the beginning of the trading day. The stock's lowest day price was 888.24. Biotech Growth has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 4th of January 2025 and ending today, the 3rd of February 2025. Click here to learn more.
Business Domain Financial Services | Classification Financials |
Biotech Growth is entity of United Kingdom. It is traded as Stock on LSE exchange. The company has 31.52 M outstanding shares. More on The Biotech Growth
Moving against Biotech Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Biotech Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biotech Growth's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biotech Growth or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Biotech Growth's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Biotech Growth's managers, analysts, and investors.
Environment Score | Governance Score | Social Score |
| Thematic Idea | IT (View all Themes) | ||||
| Business Concentration | Asset Management & Custody Banks, Financial Services, IT, Financials, Capital Markets, Asset Management, Financial Services, Computing (View all Sectors) | ||||
Biotech Growth's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Biotech Growth's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsBiotech Growth can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Biotech Growth's financial leverage. It provides some insight into what part of Biotech Growth's total assets is financed by creditors.
| |||||
The Biotech Growth (BIOG) is traded on London Exchange in UK and employs 1 people. Biotech Growth is listed under Asset Management & Custody Banks category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 266.99 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biotech Growth's market, we take the total number of its shares issued and multiply it by Biotech Growth's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biotech Growth operates under Capital Markets sector and is part of Financials industry. The entity has 31.52 M outstanding shares.
Biotech Growth generates negative cash flow from operations
Check Biotech Growth Probability Of Bankruptcy
Ownership AllocationBiotech Growth holds a total of 31.52 Million outstanding shares. Nearly 69.92 percent of Biotech Growth outstanding shares are held by general public with 0.72 (percent) owned by insiders and only 29.36 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Biotech Ownership Details
Biotech Growth Risk Profiles
Although Biotech Growth's alpha and beta are two of the key measurements used to evaluate Biotech Growth's performance over the market, the standard measures of volatility play an important role as well.
Biotech Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biotech Growth without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Additional Tools for Biotech Stock Analysis
When running Biotech Growth's price analysis, check to measure Biotech Growth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotech Growth is operating at the current time. Most of Biotech Growth's value examination focuses on studying past and present price action to predict the probability of Biotech Growth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotech Growth's price. Additionally, you may evaluate how the addition of Biotech Growth to your portfolios can decrease your overall portfolio volatility.